| Tag | Content |
|---|
EnhancerAtlas ID | HS134-64153 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr9:135878640-135880820 |
Target genes | |
SNPs | | Number: 2 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GLIS2 | MA0736.1 | chr9:135879061-135879075 | CGCTGTGGGGGGTC | - | 6.47 | | GLIS3 | MA0737.1 | chr9:135879061-135879075 | CGCTGTGGGGGGTC | - | 6.15 | | PLAG1 | MA0163.1 | chr9:135879077-135879091 | GAGGCCCAAGGGGG | + | 7.52 | | TFAP2A | MA0003.3 | chr9:135878686-135878697 | AGCCTCAGGCA | + | 6.32 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_12483 | chr9:135877900-135879573 | CD34_adult | | SE_12483 | chr9:135879924-135880198 | CD34_adult | | SE_12782 | chr9:135878602-135879139 | CD34_fetal | | SE_40302 | chr9:135876986-135880827 | K562 | | SE_60080 | chr9:135843508-135881583 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH09I133001 | chr9 | 135877324 | 135880485 |
|
Enhancer Sequence | CTCTGAGGGG AATCAGAAGT CAGTCGCGTA GAGAGCATCC TGGGGAAGCC TCAGGCACCG 60
TCCGGCCTGG CCTTTCTGCT CCAAGCCCTC CCCCTGCGCC CAGCACGACC CCATCTCTGT 120
ACACTACCAT GAGATCACTG GTGGACAGCT GTCTCTACTG TGTGGCCAGC CCCAGCAGAG 180
GCTGAGGGTC GGGCACCTGG AGGTCAGGCT GGGGTCTACC ACTCCCAGCA GCTGGGTCCT 240
CTCTGCAACA GAGGGCATTC CTGGGGGCCA GCCCAGCTCC TCTGGGGATT TCTTCCCACT 300
TTGTAGACCC CAGACTTAGT GCCAATAGAA GACCACTTCT CGCAGGGTAC AAAGTCTGTT 360
CAACAAGTAT TTGCTGGGCG TCCACTCTGG GCAGGGCCTT GGCAAGACCC AGGAGAGGAG 420
ACGCTGTGGG GGGTCTGGAG GCCCAAGGGG GTTACTAAGC CCAGCCCTGG GGTTAAGGGA 480
AGTCTAATGA GGGAAGTCGA CATTTGCAAG ACAAAAAGAA TTTGATCTGT TGGAAGTGCA 540
GAGGGCTGCC CCAAGCCAAG AAAACAGCGG GGCACAAAGC CCTGGGGGAG ACAAGAGGCC 600
TCCCCTGCCC CCAGCTCTTG CCCAACCTGT TAGGGAGCAG TGCTCTAGCC AGCGCCTTCT 660
CAGGGCTTCA GGAGGCCAGT GTGCAAAGCA AGGGTGACCT AGTGGGGTCC TGGGGGCTAT 720
CCTGTTGGGG CTTGGCAGCC AGCCACATGC ATCTTTGGTC ATTGCCACGG TCACGGTCCC 780
TGCCTTCCCA TCCCTGCTGG CTCGTGGGAT GTCTACGGGG CTTGCCTGGC ACCCCCGGCC 840
CTCCTCTGCA CTCCTCAGGA AGGAAGGTTC AGGATCCCTG AGCTCAGCCT CCCCAAGGCA 900
GCTCTTTAGA AGCCTACAAT CTTAGCTGGA AACCGTCACG GTTAAGGGTT TCCTCCCGGT 960
GGCTCCCCAG CGCCCCTCAG CCCGGCCTGA GACTTATCAC TGCCCCCCAG CTGGTGCCCC 1020
CCTCCTCCTC CAACCACCTC ACCCTGGGTG ATTCAGCAAA TCTTCCCTCC ATGAGGGGAA 1080
AAACAAGAGT GAAAAATCAC AATGTCAGAT TACAAAGCCC TAACTGTAGG GCAGGCCCCT 1140
GGCAGGGAGA TAAGGGTCTC ATTCCCCACC CTCAAAGCCT CTCTGGCAGA TAAACCTCCT 1200
AGAGCAGCAT GGGCTGCACT GCTGCAGGTG TGGGGTGGGG AGGCCTGGCC TCACGGAAGT 1260
CTGGTCAGGG GACACAGGGC CCTGCCAGGA GCTGAGGGCC CACAGCTCGG CCACTGTGCA 1320
GAGCTGGCCA AAGAGGAAGT GCCACGGCCA GCATTGATGT TGCCATCCCA ACAACTGCCT 1380
TGGAGGGAAA AAGAGAAGGG CAGGGCCTTC TGAGAAAGTT CAATGACAGG ATGCCCCACA 1440
AATGCCCTTC ACCCTGGGGT GTCCCTCTGC CAGCTCAGCC TGCAAACCAT GATCCCTTGT 1500
ACGACTGCAG CCCAGCTGTG TTGCAGAAGT AAAGGTGTCT GCCCCCATGA AGCCAGCCCA 1560
GAGGAGGGAG GAGCTGGGAT GCCATTCCTG GGAGGGGGGC CTCCTCTGGG GAGGCCTGGG 1620
TGGACTTGAA GGCAGCTCAG CCTCATCTGC CCTAGAGACC TTGCCAGGAG AAATCCTGGG 1680
TCTCCAAGCC AGGAGATCTG CTAGGCTGGG AGACCTGCCC TGGGAGCCAC TTGTCAGCAG 1740
GGGACCCTGT GATTGTGGGG ATGAGGCTGG GGGTAGGAAG GGGCGGTCAC TAGGCTTCCT 1800
CTGCTGGTGG AGGACAATGA AATGATGGCT TTGAAGCTGA ACTCTGTGCT GGGCCCTGGT 1860
GCTCTAAGCA AGTCATTTCT CTACTTTTTA GCCCCGTATG CTGTCTGTAA AGTGAGATAA 1920
GAAAACCCAC CCGCAGGGCT GTCCTGGGGA GTCCAGGTGC ATGCCAAGCA GGAGTGGCAC 1980
AGGTCCTGGT CTCTGTTTCC CAGGGTTGGG GACCAGCATC TGGCTGGAAT GGGGGTGGCT 2040
TTGGGATAAG TGCCTGCATA GCTCTTGGTA TCCAGGGCCA AGGGTCCAGC TGCCCAGCAT 2100
TCTAAAGACT CTCCATTGTC TGGGGAAGCT CTCTGAGGTC ATTTCCCACA ACACCATGGG 2160
ATGGCTGCGG TGGGCTAGGG 2180
|
